107 related articles for article (PubMed ID: 11502942)
1. Lack of association between ubiquitin carboxy-terminal hydrolase L1 gene polymorphism and PD.
Savettieri G; De Marco EV; Civitelli D; Salemi G; Nicoletti G; Annesi G; Cirò Candiano IC; Quattrone A
Neurology; 2001 Aug; 57(3):560-1. PubMed ID: 11502942
[No Abstract] [Full Text] [Related]
2. Case-control study of the ubiquitin carboxy-terminal hydrolase L1 gene in Parkinson's disease.
Maraganore DM; Farrer MJ; Hardy JA; Lincoln SJ; McDonnell SK; Rocca WA
Neurology; 1999 Nov; 53(8):1858-60. PubMed ID: 10563640
[TBL] [Abstract][Full Text] [Related]
3. No genetic association of the ubiquitin carboxy-terminal hydrolase-L1 gene S18Y polymorphism with familial Parkinson's disease.
Levecque C; Destée A; Mouroux V; Becquet E; Defebvre L; Amouyel P; Chartier-Harlin MC
J Neural Transm (Vienna); 2001; 108(8-9):979-84. PubMed ID: 11716150
[TBL] [Abstract][Full Text] [Related]
4. The ubiquitin carboxy-terminal hydrolase-L1 gene S18Y polymorphism does not confer protection against idiopathic Parkinson's disease.
Mellick GD; Silburn PA
Neurosci Lett; 2000 Oct; 293(2):127-30. PubMed ID: 11027850
[TBL] [Abstract][Full Text] [Related]
5. Low frequency of pathogenic mutations in the ubiquitin carboxy-terminal hydrolase gene in familial Parkinson's disease.
Lincoln S; Vaughan J; Wood N; Baker M; Adamson J; Gwinn-Hardy K; Lynch T; Hardy J; Farrer M
Neuroreport; 1999 Feb; 10(2):427-9. PubMed ID: 10203348
[TBL] [Abstract][Full Text] [Related]
6. A polymorphic variation of serine to tyrosine at codon 18 in the ubiquitin C-terminal hydrolase-L1 gene is associated with a reduced risk of sporadic Parkinson's disease in a Japanese population.
Satoh J; Kuroda Y
J Neurol Sci; 2001 Aug; 189(1-2):113-7. PubMed ID: 11535241
[TBL] [Abstract][Full Text] [Related]
7. ACT and UCH-L1 polymorphisms in Parkinson's disease and age of onset.
Wang J; Zhao CY; Si YM; Liu ZL; Chen B; Yu L
Mov Disord; 2002 Jul; 17(4):767-71. PubMed ID: 12210873
[TBL] [Abstract][Full Text] [Related]
8. An Ile93Met substitution in the UCH-L1 gene is not a disease-causing mutation for idiopathic Parkinson's disease.
Shi Q; Tao E
Chin Med J (Engl); 2003 Feb; 116(2):312-3. PubMed ID: 12775255
[TBL] [Abstract][Full Text] [Related]
9. [Association of two polymorphisms in ubiquitin carboxy-terminal hydrolase-L1 gene with Parkinson's disease in Shanghai].
Hao YX; Zhang J; Fang CP; Zhang Q; Zhang JR; Shen Q
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2008 Jun; 25(3):272-5. PubMed ID: 18543214
[TBL] [Abstract][Full Text] [Related]
10. Mutation analysis and association studies of the ubiquitin carboxy-terminal hydrolase L1 gene in Huntington's disease.
Nazé P; Vuillaume I; Destée A; Pasquier F; Sablonnière B
Neurosci Lett; 2002 Aug; 328(1):1-4. PubMed ID: 12123845
[TBL] [Abstract][Full Text] [Related]
11. Intron-exon structure of ubiquitin c-terminal hydrolase-L1.
Leroy E; Boyer R; Polymeropoulos MH
DNA Res; 1998 Dec; 5(6):397-400. PubMed ID: 10048490
[No Abstract] [Full Text] [Related]
12. The Ile93Met mutation in the ubiquitin carboxy-terminal-hydrolase-L1 gene is not observed in European cases with familial Parkinson's disease.
Harhangi BS; Farrer MJ; Lincoln S; Bonifati V; Meco G; De Michele G; Brice A; Dürr A; Martinez M; Gasser T; Bereznai B; Vaughan JR; Wood NW; Hardy J; Oostra BA; Breteler MM
Neurosci Lett; 1999 Jul; 270(1):1-4. PubMed ID: 10454131
[TBL] [Abstract][Full Text] [Related]
13. S18Y polymorphism in the UCH-L1 gene and Parkinson's disease: evidence for an age-dependent relationship.
Elbaz A; Levecque C; Clavel J; Vidal JS; Richard F; Corrèze JR; Delemotte B; Amouyel P; Alpérovitch A; Chartier-Harlin MC; Tzourio C
Mov Disord; 2003 Feb; 18(2):130-7. PubMed ID: 12539205
[TBL] [Abstract][Full Text] [Related]
14. Mutation analysis and association studies of the UCHL1 gene in German Parkinson's disease patients.
Wintermeyer P; Krüger R; Kuhn W; Müller T; Woitalla D; Berg D; Becker G; Leroy E; Polymeropoulos M; Berger K; Przuntek H; Schöls L; Epplen JT; Riess O
Neuroreport; 2000 Jul; 11(10):2079-82. PubMed ID: 10923647
[TBL] [Abstract][Full Text] [Related]
15. Complex interactions in Parkinson's disease: a two-phased approach.
Maraganore DM; de Andrade M; Lesnick TG; Farrer MJ; Bower JH; Hardy JA; Rocca WA
Mov Disord; 2003 Jun; 18(6):631-6. PubMed ID: 12784265
[TBL] [Abstract][Full Text] [Related]
16. Expression of alpha-synuclein, parkin, and ubiquitin carboxy-terminal hydrolase L1 mRNA in human brain: genes associated with familial Parkinson's disease.
Solano SM; Miller DW; Augood SJ; Young AB; Penney JB
Ann Neurol; 2000 Feb; 47(2):201-10. PubMed ID: 10665491
[TBL] [Abstract][Full Text] [Related]
17. Association studies of multiple candidate genes for Parkinson's disease using single nucleotide polymorphisms.
Momose Y; Murata M; Kobayashi K; Tachikawa M; Nakabayashi Y; Kanazawa I; Toda T
Ann Neurol; 2002 Jan; 51(1):133-6. PubMed ID: 11782995
[TBL] [Abstract][Full Text] [Related]
18. S18Y in ubiquitin carboxy-terminal hydrolase L1 (UCH-L1) associated with decreased risk of Parkinson's disease in Sweden.
Carmine Belin A; Westerlund M; Bergman O; Nissbrandt H; Lind C; Sydow O; Galter D
Parkinsonism Relat Disord; 2007 Jul; 13(5):295-8. PubMed ID: 17287139
[TBL] [Abstract][Full Text] [Related]
19. Genetic association between Ubiquitin Carboxy-terminal Hydrolase-L1 gene S18Y polymorphism and sporadic Alzheimer's disease in a Chinese Han population.
Xue S; Jia J
Brain Res; 2006 May; 1087(1):28-32. PubMed ID: 16626667
[TBL] [Abstract][Full Text] [Related]
20. Monogenic Parkinsonisms and the genetics of Parkinson's disease.
Bonifati V
Funct Neurol; 2001; 16(1):35-44. PubMed ID: 11396270
[No Abstract] [Full Text] [Related]
[Next] [New Search]
